Journal of Assisted Reproduction and Genetics

, Volume 16, Issue 4, pp 170–175 | Cite as

Advantages of Day 4 Embryo Transfer in Patients Undergoing Preimplantation Genetic Diagnosis of Aneuploidy

  • Luca Gianaroli
  • M. Cristina Magli
  • Santiago Munné
  • Daniela Fortini
  • Anna P. Ferraretti
Article

Abstract

Purpose:Following preimplantation genetic diagnosis of aneuploidy, embryo transfer was executed on day 4, with the aim of providing more time for expanding from six to nine the number of diagnosed chromosomes per single cell (Group 2; 45 cycles). The results obtained were compared to those derived from conventional day 3 transfer (Group 1; 71 cycles).

Methods:For multicolor fluorescence in situ hybridization analysis, two panels of probes were used: the first, specific for chromosomes XY, 13, 16, 18, and 21, was tested in all patients (Groups 1 and 2); the second was implemented only in Group 2 patients for the detection of chromosomes 14, 15, and 22.

Results:A total of 406 embryos underwent fluorescence in situ hybridization analysis in Group 1, and 236 in Group 2. Comparable percentages of both chromosomal abnormalities (61% and 62%) and pregnancy and implantation rates (36% and 24.5% in Group 1, 41% and 23.6% in Group 2) resulted, regardless of the higher mean age in Group 2.

Conclusions:The diagnosis of the nine chromosomes which are most frequently associated with aneuploidy in humans could have an immediate impact on the rate of spontaneous abortions. Additional advantages are represented by the more accurate morphological evaluation of euploid embryos; the advanced compaction, which means that embryos are less exposed to damage during the transfer procedure; and the possibility of performing a reanalysis in cases where a fluorescence in situ hybridization diagnosis is not obtained.

aneuploidy FISH analysis preimplantation genetic diagnosis spontaneous abortions 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Plachot M, Mandelbaum J: Oocyte maturation, fertilization and embryonic growth in vitro. Br Med Bull 1990;46:675-694Google Scholar
  2. 2.
    Delhanty JDA, Griffin DK, Handyside AH, Harper J, Atkinson GH, Pieters MH, Winston RM: Detection of aneuploidy and chromosomal mosaicism in human embryos during preimplantation sex determination by fluorescent in situ hybridization (FISH). Hum Mol Genet 1993;2:1183-1185Google Scholar
  3. 3.
    Munné S, Alikani M, Tomkin G, Grifo J, Cohen J: Embryo morphology, developmental rates and maternal age are correlated with chromosomal abnormalities. Fertil Steril 1995;64:382-391Google Scholar
  4. 4.
    Verlinsky Y, Cieslak J, Freidine M, Ivakhnenko V, Wolf G, Kovalinskaya L, White M, Lifchez A, Kaplan B, Moise J, Valle J, Ginsberg N, Strom C, Kuliev A: Polar body diagnosis of common aneuploidies by FISH. J Assist Reprod Genet 1996;13:157-162Google Scholar
  5. 5.
    Gianaroli L, Magli MC, Munné S, Fiorentino A, Montanaro N, Ferraretti AP: Will preimplantation genetic diagnosis assist patients with a poor prognosis to achieve pregnancy? Hum Reprod 1997;12:1762-1767Google Scholar
  6. 6.
    Gianaroli L, Magli MC, Ferraretti AP, Fiorentino A, Garrisi J, Munné S: Preimplantation genetic diagnosis increases the implantation rate in human in vitro fertilization by avoiding the transfer of chromosomally abnormal embryos. Fertil Steril 1997;68:1128-1131Google Scholar
  7. 7.
    Magli MC, Gianaroli L, Munné S, Ferraretti AP: Incidence of chromosomal abnormalities from a morphologically normal cohort of embryos in poor-prognosis patients. J Assist Reprod Genet 1998;15:297-301Google Scholar
  8. 8.
    Ferraretti AP, Magli MC, Feliciani E, Montanaro N, Gianaroli L: Relationship of timing agonist administration in the cycle phase to the ovarian response to gonadotropins in the long down-regulation protocols for assisted reproductive technologies. Fertil Steril 1996;65:114-121Google Scholar
  9. 9.
    Munné S, Lee A, Rosewaks Z, Grifo J, Cohen J: Diagnosis of major chromosome aneuploidies in human preimplantation embryos. Hum Reprod 1993;8:2185-2191Google Scholar
  10. 10.
    Munné S, Marquez C, Magli C, Morton P, Morrison L: Scoring criteria for preimplantation genetic diagnosis of numerical abnormalities for chromosomes X, Y, 13, 16, 18 and 21. Mol Hum Reprod 1998;4:863-870Google Scholar
  11. 11.
    Munné S, Weier U: Simultaneous enumeration of chromosomes 13, 18, 21, X and Y in interphase cells for preimplantation genetic diagnosis. Cytogenet Cell Genet 1996;75:263-270Google Scholar
  12. 12.
    Grifo JA, Giatras K, Tang YX, Krey LC: Successful outcome with day 4 embryo transfer after preimplantation diagnosis for genetically transmitted diseases. Hum Reprod 1998;13:1656-1659Google Scholar
  13. 13.
    Menezo Y, Hazout A, Dumont M, Herbaut N, Nicollet B: Co-culture of embryos on Vero cells and transfer of blastocysts in humans. Hum Reprod 1992;Suppl 1:101-106Google Scholar
  14. 14.
    Dawson KJ, Conaghan J, Ostera GR, Winston RM, Hardy K: Delaying transfer to the third day post-insemination, to select non arrested embryos, increases development to the fetal heart stage. Hum Reprod 1995;10:177-182Google Scholar
  15. 15.
    Jones GM, Trounson, AO, Gardner DK, Kausche A, Lolatgis N, Wood C: Evolution of a culture protocol for successful blastocyst development and pregnancy. Hum Reprod 1998;13:169-177Google Scholar
  16. 16.
    Magli MC, Fortini D, Gianaroli L, et al.: Performance of thawed biopsied embryos. In Abstracts from the 14th ESHRE Meeting. Hum Reprod 1998;13:131 (abstr R-119)Google Scholar

Copyright information

© Plenum Publishing Corporation 1999

Authors and Affiliations

  • Luca Gianaroli
    • 1
  • M. Cristina Magli
    • 1
  • Santiago Munné
    • 2
  • Daniela Fortini
    • 1
  • Anna P. Ferraretti
    • 1
  1. 1.S.I.S.M.E.R., Reproductive Medicine UnitBolognaItaly
  2. 2.St. Barnabas Medical CenterLivingston

Personalised recommendations